Skip to main content Accessibility help
×
Home

Doing The Right Thing (and Figuring Out What That Is)

  • Barry M. Farr (a1)
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Doing The Right Thing (and Figuring Out What That Is)
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Doing The Right Thing (and Figuring Out What That Is)
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Doing The Right Thing (and Figuring Out What That Is)
      Available formats
      ×

Abstract

  • An abstract is not available for this content so a preview has been provided below. To view the full text please use the links above to select your preferred format.

Copyright

Corresponding author

References

Hide All
1. Klevens, R, Edwards, J, Tenover, F, McDonald, L, Horan, T, Gaynes, R. National Nosocomial Infections Surveillance System. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis 2006; 42:389391.
2. Abramson, MA, Sexton, DJ. Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: at what costs? Infect Control Hosp Epidemiol 1999; 20:408411.
3. Cheng, AF, French, GL. Methicillin-resistant Staphylococcus aureus bacteremia in Hong Kong. J Hosp Infect 1988; 12:91101.
4. Stone, PW, Larson, E, Kawar, LN. A systematic audit or economic evidence linking nosocomial infections and infection control interventions: 1990-2000. Am J Infect Control 2002; 30:145152.
5. Cosgrove, SE, Qi, Y, Kaye, KS, Harbarth, S, Karchmer, AW, Carmeli, Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005; 26:166174.
6. Reed, SD, Friedman, JY, Engemann, JJ, et al. Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 2005; 26:175183.
7. McHugh, CG, Riley, LW. Risk factors and costs associated with methicillin-resistant Staphylococcus aureus bloodstream infections. Infect Control Hosp Epidemiol 2004; 25:425430.
8. Stosor, V, Peterson, L, Postelnick, M, Noskin, G. Enterococcus faecium bacteremia: does vancomycin resistance make a difference? Arch Intern Med 1998; 158:522527.
9. Cosgrove, SE, Sakoulas, G, Perencevich, EN, Schwaber, MJ, Karchmer, AW, Carmeli, Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bactermia: a mclaneta-analysis. Clin Infect Dis 2003; 36:5359.
10. Whitby, M, McLaws, ML, Berry, G. Risk of death from methicillin-resistant Staphylococcus aureus bacteraemia: a meta-analysis. Med J Aust 2001; 175:264267.
11. Salgado, CD, Farr, BM. Outcomes associated with vancomycin resistant enterococci: a meta-analysis. Infect Control Hosp Epidemiol 2003; 24:690698.
12. Diaz Granados, CA, Zimmer, SM, Klein, M, Jernigan, JA. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis 2005;41:327333.
13. Shitrit, P, Gottesman, BS, Katzir, M, Kilman, A, Ben-Nissan, Y, Chowers, M. Active surveillance for methicillin-resistant Staphylococcus aureus (MRSA) decreases the incidence of MRSA bacteremia. Infect Control Hosp Epidemiol 2006; 27:10041008 (in this issue).
14. Clancy, M, Graepler, A, Wilson, M, Douglas, I, Johnson, J, Price, C. Active screening in high-risk units is an effective and cost-avoidant method to reduce the rate of methicillin-resistant Staphylococcus aureus infection in the hospital. Infect Control Hosp Epidemiol 2006; 27:10091017 (in this issue).
15. Sommer, A. SARS: paradigm for an emerging pathogen in a global community. Paper presented at: 14th Annual Meeting of The Society for Healthcare Epidemiology of America; Philadelphia, PA; April 17, 2004.
16. Seto, WH, Tsang, D, Yung, RW, et al., Advisors of Expert SARS Group of Hospital Authority. Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet 2003; 361:15191520.
17. Lipsitch, M, Cohen, T, Cooper, B, et al. Transmission dynamics and control of severe acute respiratory syndrome. Science 2003; 300:19661970.
18. Beck-Sague, CM, Dooley, SW, Hutton, MD, et al. Outbreak of multidrug-resistant tuberculosis among persons with HIV infection in an urban hospital: transmission to staff and patients and control measures. JAMA 1992; 268:12801286.
19. Muto, CA, Jernigan, JA, Ostrowksy, BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus . Infect Control Hosp Epidemiol 2003; 24:362386.
20. Farr, BM. What to think if the results of the National Institutes of Health randomized trial of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus control measures are negative (and other advice to young epidemiologists): a review and an au revoirr. Infect Control Hosp Epidemiol 2006; 27:10961106 (in this issue).
21. Salgado, CD, Farr, BM. The importance of infection control in controlling antimicrobial-resistant pathogens. In: Jarvis, WR, ed. Bennett and Brach-man's Hospital Infections. 5th ed. Lippincott Williams & Wilkins; Philadelphia (in press).
22. Urth, T, Juul, G, Skov, R, Schonheyder, HC. Spread of a methicillin-resistant Staphylococcus aureus ST80-IV clone in a Danish community. Infect Control Hosp Epidemiol 2005; 26:144149.
23. Dailey, L, Coombs, GW, O'Brien, FG, et al. Methicillin-resistant Staphylococcus aureus, Western Australia. Emerg Infect Dis 2005; 11:15841590.
24. West, TE, Guerry, C, Hiott, M, Morrow, N, Ward, K, Salgado, CD. Effect of targeted surveillance for control of methicillin-resistant Staphylococcus aureus in a community hospital system. Infect Control Hosp Epidemiol 2006; 27:233238.
25. Lucet, J, Chevret, S, Durand-Zaleski, I, Chastang Cregnier, B. Prevalence and risk factors for carriage of methicillin resistant Staphylococcus aureus at admission to the intensive care unit. Arch Intern Med 2003; 163:181188.
26. Bjorholt, I, Haglind, E. Cost-savings achieved by eradication of epidemic methicillin-resistant Staphylococcus aureus (EMRSA)–16 from a large teaching hospital. Eur J Clin Microbiol Infect Dis 2004; 23:688695.
27. Vriens, M, Blok, H, Fluit, A, Troelstra, A, van der Werken, C, Verhoef, J. Costs associated with a strict policy to eradicate methicillin-resistant Staphylococcus aureus in a Dutch University Medical Center: a 10-year survey. Eur J Clin Microbiol Infect Dis 2002; 21:782786.
28. Karchmer, TB, Durbin, LJ, Simonton, BM, Farr, BM. Cost-effectiveness of active surveillance cultures and contact/droplet precautions for control of methicillin-resistant Staphylococcus aureus . J Hosp Infect 2002; 51:126132.
29. Papia, G, Louie, M, Tralla, A, Johnson, C, Collins, V, Simor, AE. Screening high-risk patients for methicillin-resistant Staphylococcus aureus on admission to the hospital: is it cost effective? Infect Control Hosp Epidemiol 1999; 20:473477.
30. Chaix, C, Durand-Zaleski, I, Alberti, C, Brun-Buisson, C. Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. JAMA 1999;282:17451751.
31. Jernigan, JA, Clemence, MA, Stott, GA, et al. Control of methicillin resistant Staphylococcus aureus at a university hospital: one decade later. Infect Control Hosp Epidemiol 1995; 16:686696.
32. Muto, CA, Giannetta, ET, Durbin, LJ, Simonton, BM, Farr, BM. Cost-effectiveness of perirectal surveillance cultures for controlling vancomycin-resistant Enterococcus . Infect Control Hosp Epidemiol 2002; 23:429435.
33. Montecalvo, MA, Jarvis, WR, Uman, J, et al. Costs and savings associated with infection control measures that reduced transmission of vancomycin-resistant enterococci in an endemic setting. Infect Control Hosp Epidemiol 2001; 22:437442.
34. Bronstein, M, Kaye, K, Sexton, D. Gown utilization as a measure of cost of methicillin-resistant Staphylococcus aureus (MRSA) screening. In: Program and abstracts of the 12th Annual Meeting of the Society for Healthcare Epidemiology of America; April 6-9, 2002; Salt Lake City, UT. Abstract 47.
35. Calfee, DP, Farr, BM. Infection control and cost control in the era of managed care. Infect Control Hosp Epidemiol 2002; 23:407410.
36. Peterson, L. Lessons to be shared in successful reductions of infections. Paper presented at: Illinois Quality Leadership Conference—Focusing on Reducing and Eliminating Infections. Naperville, IL: Illinois Hospital Association and Metropolitan Chicago Healthcare Council; May 24, 2006.
37. Warren, DK, Guth, RM, Coopersmith, CM, Merz, LR, Zack, JE, Fraser, VJ. Epidemiology of methicillin-resistant Staphylococcus aureus colonization in a surgical intensive care unit. Infect Control Hosp Epidemiol 2006; 27:10321040 (in this issue).
38. Girou, E, Pujade, G, Legrand, P, Cizeau, F, Brun-Buisson, C. Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high-risk hospital areas with a high level of endemic MRSA. Clin Infect Dis 1998; 27:543550.
39. Lucet, JC, Chevret, S, Durand-Zaleski, I, Chastang, C, Regnier, B, Multicenter Study Group. Prevalence and risk factors for carriage of methicillin-resistant Staphylococcus aureus at admission to the intensive care unit: results of a multicenter study. Arch Intern Med 2003; 163:181188.
40. Coello, R, Jimenez, J, Garcia, M, et al. Prospective study of infection, colonization and carriage of methicillin-resistant Staphylococcus aureus in an outbreak affecting 990 patients. Eur J Clin Microbiol Infect Dis 1994; 13:7481.
41. Sanford, MD, Widmer, AF, Bale, MJ, Jones, RN, Wenzel, RP. Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus . Clin Infect Dis 1994; 19:11231128.
42. Lai, KK, Fontecchio, S, Melvin, Z, Baker, SP. Impact of alcohol-based, waterless hand antiseptic on the incidence of infection and colonization with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 2006;27:10181024 (in this issue).
43. Boyce, JM, Pittet, D, Healthcare Infection Control Practices Advisory Committee, Society for Healthcare Epidemiology of America, Association for Professionals in Infection Control, Infectious Diseases Society of America Hand Hygiene Task Force. Guideline for hand hygiene in healthcare settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. MMWR Recomm Rep 2002; 51(RR-16):156.
44. Muller, A, Denizot, V, Mouillet, S, et al. Lack of correlation between consumption of alcohol-based solutions and adherence to guidelines for hand hygiene. J Hosp Infect 2005; 59:163164.
45. Muto, CA, Sistrom, MG, Farr, BM. Hand hygiene rates unaffected by installation of dispensers of a rapidly acting hand antiseptic. Am J Infect Control 2000; 28:273276.
46. Bischoff, WE, Reynolds, TM, Hall, GO, Wenzel, RP, Edmond, MB. Molecular epidemiology of vancomycin-resistant Enterococcus faecium in a large urban hospital over a 5-year period. J Clin Microbiol 1999; 37:39123916.
47. Bischoff, WE, Reynolds, TM, Sessler, CN, Edmond, MB, Wenzel, RP. Handwashing compliance by health care workers: the impact of introducing an accessible, alcohol-based hand antiseptic. Arch Intern Med 2000; 160:10171021.
48. Huang, S, Yokoe, D, Rego, V, et al. Impact of ICU surveillance for MRSA on bacteremia. In: Program and abstracts of the 43rd Annual Meeting of the Infectious Diseases Society of America; Oct 6-9, 2005; San Francisco, CA. Abstract 1074.
49. Pittet, D, Hugonnet, S, Harbarth, S, et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme [published correction appears in Lancet 2000; 356:2196]. Lancet 2000; 356:13071312.
50. Harbarth, S, Martin, Y, Rohner, P, Henry, N, Auckenthaler, R, Pittet, D. Effect of delayed infection control measures on a hospital outbreak of methicillin-resistant Staphylococcus aureus . J Hosp Infect 2000; 46:4349.
51. Goldmann, D. System failure versus personal accountability—the case for clean hands. N Engl J Med 2006; 355:121123.
52. Zachary, KC, Bayne, PS, Morrison, VJ, Ford, DS, Silver, LC, Hooper, DC. Contamination of gowns, gloves, and stethoscopes with vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 2001; 22:560564.
53. Boyce, J, Chenevert, C. Isolation gowns prevent health care workers (HCWs) from contaminating their clothing, and possibly their hands, with methicillin-resistant Staphylococcus aureus (MRSA) and resistant enterococci. In: Program and abstracts of the 8th Annual Meeting of the Society for Healthcare Epidemiology of America; Orlando, FL; 1998. Abstract S74.
54. Tiemersma, EW, Bronzwaer, SL, Lyytikainen, O, et al. Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg Infect Dis 2004; 10:16271634.
55. Boyce, JM, Cookson, B, Christiansen, K, et al. Methicillin-resistant Staphylococcus aureus . Lancet Infect Dis 2005; 5:653663.

Doing The Right Thing (and Figuring Out What That Is)

  • Barry M. Farr (a1)

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed